Newborn screening programs for spinal muscular atrophy worldwide: Where we stand and where to go
Neuromuscular Disorders2021Vol. 31(6), pp. 574–582
Citations Over TimeTop 1% of 2021 papers
Tamara Dangouloff, Eva Vrščaj, Laurent Servais, Damjan Osredkar, Thierry Adoukonou, Omid Aryani, Nina Barišić, Fahad A. Bashiri, Lailá Bastaki, Afaf Benitto, Tawfeg Ben Omran, Guenther Bernert, Enrico Bertini, Patricia Borde, Peter Born, Rose-Mary Boustani, Nina Butoianu, Claudia Castiglioni, Feriha Ćatibušić, H.S. Chan, Yin‐Hsiu Chien, Kyproula Christodoulou, Donniphat Dejsuphong, Michelle A. Farrar, Duma Filip, Nathalie Goemans, Kokou Mensah Guinhouya, Jana Haberlová, Kinga Hadzsiev, Kristine Hovhannesyan, Pirjo Isohanni, Nelica Ivanović Radović, David Jacquier, Alusine Jalloh, Maria Jędrzejowska, Gwen Kandawasvika, Celestin Kaputu, Nfwama Kawatu, Kristin D. Kernohan, Janbernd Kirschner, Barbara Klink, Sherry Kodsy, Ange-Éric Kouame-Assouan, Ružica Kravljanac, Madara Kreile, Ivan Litvinenko, Hugh J. McMillan, Sandra Lucía Restrepo Mesa, Inaam Mohamed, Liljana Muaremoska Kanzoska, Yoram Nevo, Séraphin Nguefack, Kafula Lisa Nkole, Gina O’Grady, Declan O’Rourke, Maryam Oskoui, Flávia Piazzon, Dimitri Poddighe, Audronė Prasauskienė, Juan Carlos Prieto, Magnhild Rasmussen, Santara Razafindrasata, Narayan Chandra Saha, Kayoko Saito, Foksouna Sakadi, Modibo Sangaré, Mary Schroth, L. V. Shalkevich, Andriy Shatillo, Renu Suthar, Léna Szabó, Nana Nino Tatishvili, Mériem Tazir, Eduardo F. Tizzano, Haluk Topaloğlu, M. Tulinius, Ludo van der Pol, Gabriel Vázquez, D. Vlodavets, Jithangi Wanigasinghe, Jo M. Wilmshurst, Hui Xiong, Dimitrios Zafeiriou, Eleni Zamba
Related Papers
- → Mammalian Models of Spinal Muscular Atrophy(2016)10 cited
- → Pharmacological and clinical profile of Onasemnogene Aveparvovec, the first gene therapy for spinal muscular atrophy (SMA)(2021)3 cited
- → Recent research on the treatment of spinal muscular atrophy.(2022)2 cited
- → Efficacy and safety of nusinersen in children with later-onset spinal muscular atrophy (SMA): results of the phase 3 CHERISH study(2017)1 cited
- → Perspectives on models of spinal muscular atrophy for drug discovery(2004)17 cited